86-21-64556180

cpd-service@caerulumpharma.com

Home
About Us
Products
Solutions
FAQs
Contact Us

Home
Cas 151533-22-1 – L-methylfolate

Products Categories

Antineoplastic
- ACC
- Adenosine A2A
- ALK
- Androgen receptor inhibitor
- Apoptosis stimulant
- ATR
- AXL
- BCl2-BH4
- Bcr-Abl
- BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating agent
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- IDO
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Hypoglycemic drugs
- DPP-4
- SGLT-1
- SGLT-2
Others
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- mAChRs
- NF-κB
- NRTI
- PPAR
- RIP1
- S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

Cas 151533-22-1 – L-methylfolate - Manufacturers, Factory, Suppliers From China

Cas 151533-22-1 – L-methylfolate, , , , Cas 151533-22-1 – L-methylfolate,

Fast delivery 222638-67-7 - Bardoxolone –...
Well-designed Gemcitabine Hydrochloride Powder ...
Low price for Cas No.:105-41-9 - BAR 502 ̵...
Big Discount Korean Red Ginseng Tablet - BGB-3...
China New Product Deworming Raw Material - Vac...
Factory Promotional CYC 065 - BAR 502 – ...
Factory Price Flunixin Meglumin Api 42461-84-7 ...
factory Outlets for Usp Grade Daunorubicin - T...
OEM/ODM China Auricularia Auricula Powder - Oz...
China Wholesale Telmisartan Powder - Flibanser...
CE Certificate Cas 697739-03-0 - CP-456773 sod...
Low MOQ for Antineoplastic 99% Nilotinib - DEL...
Professional China Gemcitabine 98% - ARS-1630 ...
factory low price Raw Material Carmustine - P...

Contact Us

3rd Floor, Building 4, 3918 Daye Road, Fengxian District, Shanghai
86-21-64556180
Within China:
sales-cpd@caerulumpharma.com
International:
cpd-service@caerulumpharma.com

Inquiry

For inquiries about our products, please leave your email with us and we will be in touch within 24 hours.Inquiry

Latest News

Top 7 Trends In Pharmaceutical Research I...

Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...
ARS-1620: A promising new inhibitor for K...

According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...
AstraZeneca receives regulatory boost for...

AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

FAQs
Downloadable
Contact Us

QR Code

WhatsApp Online Chat !